Lipigon Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Lipigon Pharmaceuticals has a total shareholder equity of SEK28.4M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK33.6M and SEK5.2M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr31.93m |
| Equity | kr28.45m |
| Total liabilities | kr5.16m |
| Total assets | kr33.60m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LPGO's short term assets (SEK33.6M) exceed its short term liabilities (SEK5.2M).
Long Term Liabilities: LPGO's short term assets (SEK33.6M) do not cover its long term liabilities (SEK-1,000.0).
Debt to Equity History and Analysis
Debt Level: LPGO is debt free.
Reducing Debt: LPGO has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LPGO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LPGO has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 16% each year.